Stock screenerAll disclosures →
EDGAR →
SGMT
Conviction 92HealthcareScan · Mon, Aug 10, 2026SGMT$9.60+5.96%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.61M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price9.60
Change+5.96%
Gap-1.32%
Rel volume7.71×
Avg volume1.46M
Avg $ vol12.04M
SMA 207.70
SMA 507.29
SMA 2006.61
Price vs 50+31.63%
Price vs 200+45.21%
MA stackbullish
50/200 cross—
Supertrendup · 7.49
RSI (14)75
MACD hist0.23
MACD crossbull · 4d
Stoch %K / %D100 / 96
ADX (14)20
+DI / −DI36 / 12
RSI divergence—
MACD divergence—
ATR %+5.63%
ADR %6.85%
52w high9.60
52w low4.55
From 52w high+0.00%
Above 52w low+110.99%
New 52w highYes
SqueezeOff
Bollinger width38.69%
%B1.14
Donchian pos99.68%
Donchian high9.61
Donchian low6.50
AVWAP (52w high)7.31
vs AVWAP high+31.28%
AVWAP (52w low)7.70
vs AVWAP low+24.60%
OBV trendUp
Chaikin MF (20)0.56
Today vs 20d7.71×
Avg vol (14d)1.61M
Avg vol (20d)1.46M
Avg $ vol (20d)12.04M
Market cap294.48M
RS 3m (vs SPY)+12.89%
RS 6m (vs SPY)+52.43%
RS line new highYes
Trend template6/8
Technical rank94.8
1 week+34.27%
1 month+30.26%
3 months+24.51%
6 months+72.97%
1 year+6.08%
YTD+60.27%
P/E-5.77
P/B2.87
P/S147.24
P/FCF—
EPS-1.58
Div yield—
ROE-49.81%
ROA-47.36%
Debt/Eq—
Current20.34
EV/EBITDA—
Gross margin—
Net margin—
Rev growth0.00%
EPS growth-12.01%
Price target28.29
Target upside194.69%
Analyst ratingBuy
Institutional38.54%
Ent. value257.85M
Revenue2M
Net income-10.65M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.02M
Employees16
ListedFri, Jul 14, 2023
Free float28.28M
Float %91.2%
Short interest9.74M
Days to cover9.2d
Short volume70.8%
Squeeze score100 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.33 vs −$0.39
Last surprise+15.4% beat
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank94.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance8.03
Support6.37
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SGMT
No recent disclosed trades by Congress in SGMT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SGMT · 5 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Happel David President & CEO · Series A Common Stock · 2026-07-20 | Sell | 64.05K | $497K | 2026-07-20 | 2026-07-22 |
Kemble George Director · Series A Common Stock · 2026-07-20 | Sell | 18.84K | $141K | 2026-07-20 | 2026-07-22 |
Happel David President & CEO · Stock Option (Right to Buy) · 2026-05-28 | Grant | 300K | $0 | 2026-05-28 | 2026-06-01 |
Rozek Elizabeth Chief Legal & Admin. Officer · Stock Option (Right to Buy) · 2026-05-28 | Grant | 100K | $0 | 2026-05-28 | 2026-06-01 |
Grauer Andreas Chief Medical Officer · Stock Option (Right to Buy) · 2026-05-28 | Grant | 35K | $0 | 2026-05-28 | 2026-06-01 |
Chauche Thierry Chief Financial Officer · Stock Option (Right to Buy) · 2026-05-28 | Grant | 50K | $0 | 2026-05-28 | 2026-06-01 |
Grauer Andreas Chief Medical Officer · Stock Option (Right to Buy) · 2026-04-20 | Grant | 264.76K | $0 | 2026-04-20 | 2026-05-14 |
SEC filings
EDGAR filings in SGMT · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.